Ricardo Carl Elciario Dolmetsch,Fabrizio Gasparini,Baltazar Gomez-Mancilla,Donald Johns
申请号：
US16634986
公开号：
US20200237721A1
申请日:
2018.07.30
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The invention relates to the use of mavoglurant, or a pharmaceutically acceptable salt thereof: in the reduction of alcohol use by an alcohol use disorder patient； in preventing relapse into alcohol use by an alcohol use disorder patient； in the promotion of alcohol abstinence by an alcohol use disorder patient； in the treatment of the symptoms of depression or anxiety associated with alcohol use disorder.
